VITRICELL
VitriCell providing solutions for cryopreservation of even the most sensitive cells based in Liège, Belgium.
VITRICELL
Industry:
Biotechnology Innovation Management Therapeutics
Founded:
2017-01-01
Address:
Belgium, Wisconsin, United States
Country:
United States
Website Url:
http://www.vitricell.com
Total Employee:
1+
Status:
Active
Total Funding:
1.01 M EUR
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail IPv6 OVH DNS OVH Mail
Similar Organizations
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Current Employees Featured
Founder
Investors List
Walloon
Walloon investment in Grant - vitricell
WBC incubator
WBC incubator investment in Grant - vitricell
Gesval
Gesval investment in Series A - vitricell
Spinventure
Spinventure investment in Series A - vitricell
Jean-Pierre Delwart
Jean-Pierre Delwart investment in Series A - vitricell
Official Site Inspections
http://www.vitricell.com
- Host name: linweb578.webhosting.be
- IP address: 5.134.7.198
- Location: Gouvy Belgium
- Latitude: 50.186
- Longitude: 5.9392
- Timezone: Europe/Brussels
- Postal: 6670
More informations about "vitricell"
Cell Matters - Crunchbase Company Profile & Funding
Cell Matters specializes in cell therapy productivity, turning cryopreservation into a competitive advantage. It offers an integrated set of GMP services, in line with regulatory, quality, and …See details»
VitriCell S.A. - Life-Sciences-Europe.com
Jun 1, 2017 · VitriCell is a biotechnology company offering innovative and effective solutions for the cryopreservation of even the most sensitive cells. Its unique technology, based on aseptic …See details»
Cell Matters Company Profile 2024: Valuation, Investors
Developer of cryopreservation technology designed to facilitate the preservation of eukaryotic cells.See details»
Cell Matters - Funding, Financials, Valuation & Investors
Cell Matters specializes in cell therapy productivity, turning cryopreservation into a competitive advantage.See details»
VitriCell - Products, Competitors, Financials, Employees, …
VitriCell focuses on cryopreservation solutions within the life sciences sector, offering standardized cryopreservation and distribution services for cell therapy markets. Use the CB …See details»
VitriCell raises over €1 million ($1.2M) in series A funding
Liège, Belgium, January 23, 2018 – VitriCell SA, a biotech company providing innovative and efficient solutions for cryopreservation of even the most sensitive cells, discloses today that it …See details»
VitriCell S.A. - BioCentury Company Profiles - BCIQ
May 17, 2018 · Enter a Company name above to access free BCIQ profiles. Historical deals and financings can be found by searching the organization's name in the BCIQ Deals and …See details»
VitriCell Raises Over $1.2M in Series A Funding
Jan 24, 2018 · VitriCell SA, a biotech company providing innovative and efficient solutions for cryopreservation of even the most sensitive cells, discloses today that it closed a series A …See details»
Cell Matters - Updates, News, Events, Signals & Triggers
Jan 23, 2018 · Cell Matters specializes in cell therapy productivity, turning cryopreservation into a competitive advantage.See details»
A cool way from academic research to company foundation
In September 2017, VitriCell SA, closed a series A round of fundraising totaling over 1 M€. This consists of equity capital of 712 k€ (Spinventure, Gesval, private investors, members of the …See details»
VitriCell S.A. - life-sciences-europe.com
Jun 1, 2017 · VitriCell is a biotechnology company offering innovative and effective solutions for the cryopreservation of even the most sensitive cells.See details»
ORBi: Detailled Reference
VITRICELL’s current product is based on a novel and user-friendly, aseptic and automatable vitrification method in sealed french straws, with bio-safe and chemically defined media. The …See details»
VitriCell Raises over €1M in in Series A Funding - FinSMEs
Jan 23, 2018 · VitriCell SA, a Liège, Belgium-based biotech company providing solutions for cryopreservation of even the most sensitive cells, closed a €1m ($1.2M) Series A round of …See details»
Solutions for Cell Cryopreservation - LinkedIn
Jan 24, 2017 · VitriCell, a spin-off from the University of Liège, provides the scientific community with a unique expertise in cryopreservation and marketing in the form of standardized and …See details»
Contacts, Employees, Board Members, Advisors & Alumni
Cell Matters has 4 current employee profiles, including CEO & Co-Founder Delphine Connan. Cell Matters specializes in cell therapy productivity, turning cryopreservation into a competitive …See details»
VITRICELL: The safest key for cryopreserving your valuable cells
VITRICELL is a future spin-off company aiming at providing standard and customized solutions for safe and efficient cryopreservation of valuable and sensible eukaryotic cells.See details»
VitriCell Stock Price, Funding, Valuation, Revenue ... - CB Insights
See VitriCell funding rounds, investors, investments, exits and more. Evaluate their financials based on VitriCell's post-money valuation and revenue.See details»
Cell Matters - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Nov 1, 2024 · Cell Matters is ranked 12,796,118 among websites globally based on its 119 monthly web visitors. Cell Matters specializes in cell therapy productivity, turning …See details»
IntegriCellâ„¢ Cryopreservation - Cryoport Systems
IntegriCellâ„¢ cryopreservation services from Cryoport Systems optimize leukapheresis-derived cell therapies by enhancing the safety, quality, and viability of manufacture-ready …See details»
Fabien Ectors - Co-Founder and CSO @ Cell Matters - Crunchbase
Fabien is co-promoter of the European (FP7-BEST Stem Cells) and First Spin-Off (DGO6-FWB) projects, which enabled the development of VitriCell’s technology and lead to the creation of …See details»